Mercapturic acid biosynthesis is mediated by a series of at least four enzymatic steps and three cell membrane transport events, and is believed to require the interorgan shuttling of the various metabolic intermediates. To identify a single cell type that can carry out all of these metabolic and transport steps, the present study examined whether HepG2 cells, a human hepatoma-derived cell line, can convert an electrophilic chemical (1-chloro-2,4-dinitrobenzene, CDNB) to its corresponding mercapturic acid (S-dinitrophenyl-N-acetylcysteine, DNP-NAC). The results demonstrate that HepG2 cells are able to convert CDNB to DNP-NAC in a dose- and time-dependent fashion. Intracellular conjugation with glutathione occurred rapidly, and the resulting glutathione S-conjugate was promptly transported into the culture medium, where it was sequentially degraded to the cysteinylglycine and cysteine S-conjugates. The cysteine conjugate was then presumably reabsorbed, and N-acetylated intracellularly to form the mercapturic acid. The mercapturic acid was found to accumulate slowly in the culture medium, such that after 4 h of incubation, 4-10% of the CDNB dose was recovered as the mercapturic acid. These data provide the first demonstration that a single cell type can carry out all of the transport and enzymatic steps required for mercapturic acid biosynthesis. HepG2 cells may provide a useful model system for studying this important detoxification pathway.